SCHEMBL9963483

SCHEMBL9963483

CN1CCN(C(=O)CNc2nc3cc4nc(Cl)sc4cc3s2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.51
STAT3 P40763 1/20 0.40
CLK1 P49759 2/20 0.40
DYRK1A Q13627 2/20 0.40
DYRK1B Q9Y463 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
POLB P06746 3/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA9 Q16790 1/20 0.38
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
FSCN1 Q16658 1/20 0.37
MELK Q14680 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963627 0.82 PTGS2 (0.53) PTGS2NPC1RAB9AALDH1A1CA1
SCHEMBL9963494 0.80 PTGS2 (0.45) PTGS2STAT3CLK1DYRK1ADYRK1B
SCHEMBL9963497 0.78 PTGS2 (0.54) PTGS2STAT3CLK1DYRK1ADYRK1B
SCHEMBL9963610 0.77 PTGS2 (0.54) PTGS2NPC1RAB9AALDH1A1CA1
SCHEMBL9963509 0.76 PTGS2 (0.52) PTGS2STAT3RAB9APOLBALDH1A1
SCHEMBL9963503 0.76 PTGS2 (0.52) PTGS2STAT3KDM1AMAOAMAOB
SCHEMBL9963603 0.76 PTGS2 (0.53) PTGS2RAB9APOLBALDH1A1
SCHEMBL9963606 0.76 PTGS2 (0.47) PTGS2RAB9APOLBALDH1A1
SCHEMBL9963479 0.76 PTGS2 (0.45) PTGS2NPC1RAB9AALDH1A1MEN1
SCHEMBL9963508 0.74 PTGS2 (0.52) PTGS2STAT3RAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 PTGS2 2872/4885STAT3 2402/4885CLK1 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.